If your life sciences startup is past early research but not yet fully commercial, funding gaps can slow progress. The BioCreate Program (Ontario) supports southern Ontario SMEs by helping move genomics and engineering biology technologies closer to market with targeted commercialization funding. The program offers up to $150,000 in repayable funding for projects that are already at Technology Readiness Level (TRL) 4 or higher.
The BioCreate Program is a funding initiative delivered by Ontario Genomics. It supports small and medium-sized businesses that are developing genomics- or engineering biology-enabled products in health, agri-food, and cleantech sectors.
Key program facts:
BioCreate is meant for companies that have proven technical feasibility and need capital to reduce risks during commercialization.
To qualify for the BioCreate Program in Ontario, your business and project must meet all of the following criteria:
Tools like GrantHub’s eligibility matcher can help you quickly check if BioCreate—and similar Ontario life sciences grants—fit your business profile.
Ontario Genomics manages the application intake. Most successful BioCreate applications follow this general process:
Check your technology stage and sector
Your technology must be past basic research. If you cannot show TRL 4 or higher, your application will not move forward.
Describe your commercialization project clearly
BioCreate does not fund discovery research. Focus on product validation, scale-up, regulatory preparation, or early market entry.
Prepare your budget and contribution plan
You must show how your $100,000+ contribution supports the project milestones.
Apply through Ontario Genomics
Applications are reviewed for technical merit, commercialization potential, and economic impact in Ontario.
Because BioCreate funding is repayable, reviewers also check if your business has a practical path to revenue.
If you need help comparing BioCreate to other programs, GrantHub’s searchable database can help you find the best fit for your project.
Ontario Genomics may provide guidance during intake, but BioCreate funding is usually used for:
Eligible costs
Ineligible costs
Applying before reaching TRL 4
Projects below TRL 4 do not qualify. BioCreate is not a research grant.
Weak commercialization plan
A strong technology is not enough. You must show market demand and potential for revenue.
Ignoring repayment requirements
This is repayable funding. Your financial projections should show realistic repayment ability.
Unclear contribution breakdown
Vague in-kind contributions raise concerns during review.
Q: Is the BioCreate Program funding repayable or non-repayable?
BioCreate funding is repayable. Repayment terms are set by Ontario Genomics and are usually tied to commercialization outcomes.
Q: How much funding can I receive from the BioCreate Program?
Eligible SMEs can receive up to $150,000, if they contribute at least $100,000 in cash or in-kind support.
Q: Does my project need to be completed in Ontario?
Yes. BioCreate-funded work must be performed in Ontario, with rare exceptions that require prior approval.
Q: How long can a BioCreate-funded project last?
Projects can last up to 18 months, depending on scope and milestones.
Q: Can early-stage startups apply?
Early-stage companies can apply if their technology has reached TRL 4 or higher and they can meet the financial contribution requirement.
Was this article helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.